Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Johnson and Johnson
Medtronic
Colorcon
Dow

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

Medicure Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for Medicure
International Patents:7
US Patents:2
Tradenames:3
Ingredients:3
NDAs:4
Patent Litigation for Medicure: See patent lawsuits for Medicure

Drugs and US Patents for Medicure

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicure ZYPITAMAG pitavastatin magnesium TABLET;ORAL 208379-002 Jul 14, 2017 RX Yes No 8,829,186 ⤷  Free Forever Trial Y Y ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride SOLUTION;INTRAVENOUS 020913-001 May 14, 1998 DISCN No No 6,770,660 ⤷  Free Forever Trial ⤷  Free Forever Trial
Medicure SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209584-001 Aug 10, 2018 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride SOLUTION;INJECTION 020912-002 Aug 31, 2016 RX Yes Yes 6,770,660 ⤷  Free Forever Trial ⤷  Free Forever Trial
Medicure ZYPITAMAG pitavastatin magnesium TABLET;ORAL 208379-001 Jul 14, 2017 DISCN Yes No 8,829,186 ⤷  Free Forever Trial Y Y ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride SOLUTION;INTRAVENOUS 020913-003 Apr 20, 2000 AP RX Yes Yes 6,770,660 ⤷  Free Forever Trial ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020912-001 May 14, 1998 DISCN No No 6,770,660 ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Medicure

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicure AGGRASTAT tirofiban hydrochloride SOLUTION;INTRAVENOUS 020913-001 May 14, 1998 5,658,929 ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride SOLUTION;INJECTION 020912-002 Aug 31, 2016 5,965,581 ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020912-001 May 14, 1998 5,978,698 ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride SOLUTION;INTRAVENOUS 020913-003 Apr 20, 2000 5,978,698 ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020912-001 May 14, 1998 6,136,794 ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride SOLUTION;INTRAVENOUS 020913-003 Apr 20, 2000 6,136,794 ⤷  Free Forever Trial
Medicure AGGRASTAT tirofiban hydrochloride SOLUTION;INJECTION 020912-002 Aug 31, 2016 6,136,794 ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for Medicure Drugs

Country Patent Number Estimated Expiration
Japan 2005532306 ⤷  Free Forever Trial
Canada 2483929 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 03092767 ⤷  Free Forever Trial
Australia 2003234596 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2011089623 ⤷  Free Forever Trial
Japan 2013516459 ⤷  Free Forever Trial
European Patent Office 1503753 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for Medicure Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2666774 LUC00167 Luxembourg ⤷  Free Forever Trial PRODUCT NAME: RELEBACTAM, EVENTUELLEMENT SOUS FORME DE MONOHYDRATE, IMIPENEME ET CILASTATINE, EVENTUELLEMENT SOUS FORME DE SEL DE SODIUM; AUTHORISATION NUMBER AND DATE: EU/1/19/1420 20200217
2203431 92666 Luxembourg ⤷  Free Forever Trial PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119
2203431 2015/009 Ireland ⤷  Free Forever Trial PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REGISTRATION NO/DATE: EU/1/14/983 20150115
1912999 1490062-5 Sweden ⤷  Free Forever Trial PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
2203431 15C0013 France ⤷  Free Forever Trial PRODUCT NAME: DASABUVIR OU UN SEL DE CELUI-CI, NOTAMMENT LE SEL DE SODIUM; REGISTRATION NO/DATE: EU/1/14/983 20150119
0268956 SPC/GB98/040 United Kingdom ⤷  Free Forever Trial PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508
0290047 SPC/GB97/078 United Kingdom ⤷  Free Forever Trial PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Express Scripts
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.